Jiutian Chemical Group Limited (C8R) AI Stock Analysis

• Market Cap: S$49.71M
• Dividend Yield: N/A
• Average Volume (3M): 5.70M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.25
• Revenue Growth: -2.43%
• EPS Growth: 52.80%
• Country: SG
• Employees: N/A
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals
• EPS (TTM): >-0.01
• Shares Outstanding: 1,988,444,000
• 10 Day Avg. Volume: 2,600,530
• 30 Day Avg. Volume: 5,701,756
• PEG Ratio: 0.03
• Price to Book (P/B): 0.46
• Price to Sales (P/S): 1.18
• P/FCF Ratio: -1.67
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 45 Neutral
• Price Target: S$0.02 ▲(20.00% Upside)

Jiutian Chemical Group Limited's overall stock score is primarily impacted by its poor financial performance, characterized by declining revenues and negative profitability. While technical analysis shows some positive trends, the valuation remains weak due to a negative P/E ratio and lack of dividend yield. The absence of earnings call data and corporate events leaves these areas unaddressed.

Positive Factors

Product and market diversification

Jiutian's broad product portfolio across specialty, agricultural and industrial chemicals and sales to domestic and international customers provides structural resilience. Diversification reduces exposure to a single end-market cycle and supports steadier demand and cross-selling over a 2–6 month horizon.

Improved leverage management

An improving debt-to-equity profile suggests management has reduced financial risk and enhanced balance sheet flexibility. Lower leverage improves the company's ability to fund working capital and strategic investments and to absorb industry cyclicality without urgent refinancing pressure over the medium term.

Positive free cash flow to net income ratio

A positive free cash flow to net income ratio indicates that the firm converts reported earnings into cash reasonably well, which supports debt servicing and reinvestment capacity. This structural cash conversion efficiency can help stabilize operations despite other cash challenges.

Negative Factors

Declining revenue trend

A negative revenue growth rate signals shrinking top-line scale, which erodes operating leverage and long-term competitiveness. Sustained revenue decline constrains the firm's ability to recover margins, invest in R&D or capex, and maintain market share across business cycles.

Negative profitability and margins

Negative gross and net margins show the business is not covering direct costs and operating expenses, a structural concern that undermines retained earnings and equity. Without durable margin restoration, the company will struggle to fund growth, pay down liabilities, or rebuild reserves.

Weak operating cash flow

Negative operating cash flow constrains the firm's ability to fund day-to-day operations and capital needs from internal sources. Over the medium term this raises dependence on external financing, increases liquidity risk, and limits strategic flexibility to respond to industry opportunities or shocks.

Jiutian Chemical Group Limited Business Overview & Revenue Model

Company Description

Jiutian Chemical Group Limited, an investment holding company, manufactures and sells chemical-based products in the People's Republic of China. The company offers dimethylformamide, which is used as a feedstock in the production of polyurethane, pharmaceutical, and agro chemical products, as well as an absorbing agent primarily in electronics, acrylic fibers, and pharmaceutical products; and methylamine, a chemical feedstock in the organic chemical industry used in various areas, such as agricultural chemicals, medicines, fuels, synthetic resins, and leather making, as well as in the production of the solvent used for chemical fibers, activating agents, and photography. It also provides sodium hydrosulfite, a crystalline powder for use in water treatment, gas purification, cleaning, and stripping, as well as in the industrial processing of textiles, leather, foods, polymers, photography, and others; industrial and consumable carbon dioxide for use in aerated beverages, tobacco, and preserving vegetables; Oxygen-18, an isotope of oxygen to produce fluorodeoxyglucose; deuterium depleted water to inhibit cancer growth; and industrial methanol. In addition, the company is involved in the sale of downstream products; and research and development of isotope technology. Jiutian Chemical Group Limited was founded in 1994 and is based in Singapore.

How the Company Makes Money

Jiutian Chemical Group Limited generates revenue through multiple streams, primarily by manufacturing and selling its chemical products to various industries. The company's revenue model is based on the volume of chemicals produced and sold, as well as the pricing strategies employed for different product lines. Key revenue streams include direct sales to manufacturers in sectors like agriculture, automotive, and construction. Additionally, Jiutian may engage in long-term contracts with major clients, providing a steady income flow. The company also benefits from strategic partnerships with distributors and suppliers, enhancing its market reach and operational efficiency. Factors contributing to its earnings include fluctuations in raw material prices, demand for specialty chemicals, and the overall health of the global chemical market.

Jiutian Chemical Group Limited Financial Statement Overview

Summary

Jiutian Chemical Group Limited is facing significant financial challenges, with declining revenues, negative profitability margins, and weak cash flow generation. While the balance sheet shows some improvement in leverage, the overall financial health is compromised by poor operational performance and cash flow issues.

Income Statement

Jiutian Chemical Group Limited has experienced a significant decline in revenue and profitability over recent years. The gross profit margin and net profit margin have turned negative, indicating the company is struggling to cover its costs. The revenue growth rate has also been negative, reflecting a shrinking top line. These factors suggest financial instability and operational challenges.

Balance Sheet

The company's balance sheet shows a moderate debt-to-equity ratio, which has improved over the years, indicating better leverage management. However, the return on equity has been negative recently, reflecting poor profitability. The equity ratio is relatively stable, suggesting a balanced asset structure, but the overall financial health is weakened by declining equity returns.

Cash Flow

Cash flow metrics reveal a challenging situation with negative operating cash flow and free cash flow. Although there is a positive free cash flow to net income ratio, indicating some efficiency in cash generation relative to net income, the overall cash flow position is concerning due to negative growth and coverage ratios.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	393.13M	243.76M	598.56M	2.43B	2.17B	1.15B
Gross Profit	-147.20M	-82.26M	-260.18M	708.41M	675.62M	274.77M
EBITDA	-141.98M	-118.22M	-321.76M	696.61M	517.79M	274.66M
Net Income	-162.31M	-147.80M	-344.64M	490.50M	324.90M	173.69M
Balance Sheet
Total Assets	1.42B	1.05B	1.29B	1.99B	1.89B	1.43B
Cash, Cash Equivalents and Short-Term Investments	698.48M	400.41M	529.62M	1.11B	773.55M	259.73M
Total Debt	234.88M	289.32M	265.88M	134.64M	228.18M	344.30M
Total Liabilities	469.16M	427.02M	523.23M	764.65M	1.08B	911.93M
Stockholders Equity	948.17M	618.04M	765.84M	1.22B	816.21M	524.74M
Cash Flow
Free Cash Flow	-356.18M	-171.63M	-511.23M	424.05M	633.54M	122.69M
Operating Cash Flow	-328.39M	-81.58M	-385.65M	434.01M	655.81M	129.02M
Investing Cash Flow	-27.72M	-89.54M	-125.70M	-9.85M	-27.68M	-10.90M
Financing Cash Flow	-53.04M	32.87M	-732.00K	-95.52M	-110.89M	5.67M

Jiutian Chemical Group Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.02
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C8R, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.03, and below the 200-day MA of 0.03, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 43.20 is Neutral, neither overbought nor oversold. The STOCH value of -144.44 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:C8R.

Jiutian Chemical Group Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
C05	46 Neutral	S$39.49M	-1.70	-19.55%	0.92%	-7.45%	-480.22%
C8R	45 Neutral	S$49.71M	-2.12	-20.85%	―	-2.43%	52.80%

Jiutian Chemical Group Limited Corporate Events

Jiutian Chemical Drops Synthetic Ammonia Investment Amid Tightening China Credit

Jiutian Chemical Group has mutually agreed with Anyang Chemical Industry Group to terminate its planned investment in a synthetic ammonia project and the lease of a urea production facility in China, after reassessing the project’s commercial viability amid tighter lending conditions and stricter collateral and repayment requirements across the Chinese banking sector. The company stated that key conditions precedent, particularly securing adequate bank financing, could not be met, but emphasized that it has incurred no material capital expenditure, faces no penalties or break fees from the termination, and does not expect any material adverse impact on its financial position for the 2025 financial year; it will continue to evaluate other strategic and investment opportunities aligned with its long-term objectives and shareholder interests.

The most recent analyst rating on (SG:C8R) stock is a Hold with a S$0.03 price target. To see the full list of analyst forecasts on Jiutian Chemical Group Limited stock, see the SG:C8R Stock Forecast page.

Jiutian Chemical Group Sees Revenue Surge Amid Strategic Production Halts

Jiutian Chemical Group Limited reported a 217% increase in revenue for the third quarter of 2025 compared to the same period in 2024, driven by higher chemical trading activities. Despite a net loss of RMB 30.34 million, the company showed improvement from the previous year’s loss, attributing this to strategic production halts and cost-control measures. The company remains focused on operational efficiency and financial discipline to seize future growth opportunities amid challenging market conditions.